Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
Price:
10.65
CNY
1.14%
Market Closed
Market Cap:
¥4.7B
Relative Value
The Relative Value of one
Zhejiang Starry Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 10.65 CNY,
Zhejiang Starry Pharmaceutical Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Zhejiang Starry Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Zhejiang Starry Pharmaceutical Co Ltd Competitors
Zhejiang Starry Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
|
4.7B CNY | 2 | -159.1 | 127.7 | 127.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 15.3 | 48.5 | 32.6 | 34.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
283.4B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.5 | 16.1 | 10.1 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.8B GBP | 5.1 | 31.7 | 15.1 | 22.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.8 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154B USD | 2.4 | 19.7 | 7.4 | 9.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124B USD | 2.6 | 17.7 | 6.9 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
